Literature DB >> 10024434

Identification and grouping of Dichelobacter nodosus, using PCR and sequence analysis.

G H John1, R Smith, K J Abraham, R P Ellis.   

Abstract

Dichelobacter nodosus is the causative agent of ovine foot rot, a disease that is a constant economic burden for many Western sheep ranches. Vaccination is one method of treating foot rot. A higher and more specific immune response is observed when monovalent vaccines are used to treat foot rot, as compared to multivalent vaccines, which incorporate all 10 major New Zealand D. nodosus serogroups. There is no single assay for specifically identifying and grouping D. nodosus for the purpose of incorporating only the desired serogroup(s) in a vaccine. A polymerase chain reaction (PCR)-based assay was used to specifically identify and group D. nodosus from a foot rot lesion. Identification and grouping was determined by predicted fragment size analysis and nucleotide sequence information. The PCR approach vastly improves the accuracy in identifying and grouping D. nodosus from a foot rot lesion. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024434     DOI: 10.1006/mcpr.1998.0210

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  2 in total

1.  Understanding the molecular epidemiology of the footrot pathogen Dichelobacter nodosus to support control and eradication programs.

Authors:  N B Buller; P Ashley; M Palmer; D Pitman; R B Richards; D J Hampson
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

2.  Multiple locus VNTR analysis highlights that geographical clustering and distribution of Dichelobacter nodosus, the causal agent of footrot in sheep, correlates with inter-country movements.

Authors:  Claire L Russell; Edward M Smith; Leonides A Calvo-Bado; Laura E Green; Elizabeth M H Wellington; Graham F Medley; Lynda J Moore; Rosemary Grogono-Thomas
Journal:  Infect Genet Evol       Date:  2013-06-07       Impact factor: 3.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.